Biologics in the prevention and treatment of graft rejection (Q36494225)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Biologics in the prevention and treatment of graft rejection	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Biologics in the prevention and treatment of graft rejection (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

author name string

Reinhard Marks

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

Jürgen Finke

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

publication date

9 May 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

published in

Seminars in Immunopathology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

page(s)

457-476

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

cites work

The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00281-006-0014-7

retrieved

21 January 2018

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00281-006-0014-7

retrieved

21 January 2018

Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF-alpha therapy for acute rejection in intestinal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab as treatment for refractory kidney transplant rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppression: practice and trends

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive therapy after human lung transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends and results for organ donation and transplantation in the United States, 2004

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiologic mechanisms of acute graft-vs.-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daclizumab to prevent rejection after cardiac transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppression following intestinal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Stu

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costimulation blockade with belatacept in renal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of response to pulse methylprednisolone therapy in renal transplant recipients with acute allograft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive drugs for kidney transplantation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized clinical trial of induction therapy with OKT3 in kidney transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel therapeutics for the treatment of graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction therapy with rabbit antithymocyte sera reduces rejection episodes in immunologically low-risk living donor renal transplant recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in graft-versus-host disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute graft-versus-host disease with monoclonal antibody OKT3. Clinical results and effect on circulating T lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campath-1H in renal transplantation: The University of Wisconsin experience.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Collaborative Transplant Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute graft-vs-host disease: pathobiology and management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16738956

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00281-006-0014-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

PubMed publication ID

16738956

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16738956

retrieved

14 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36494225&oldid=2198963336"